MMP9 and Parkinson disease: Experimental evidence also reveals that MMP9 mediates cognitive deficits in rotenone-induced PD murine models by triggering microglial activation-driven blood–brain barrier compromise and promoting apoptotic neuronal death, establishing its pivotal role in neurotoxic pathogenesis [28].